ASCLEPIUMM

Asclepiumm Taiwan Co., Ltd. was established in 2011 and is a pioneering pharmaceutical development company focused on addressing unmet medical needs in the market. The company specializes in the research and development of innovative first-in-class drugs utilizing the ASC fusion protein platform and unique peptide drug development. In 2016, Asclepiumm established three major research axes: peptides, antibodies, and fusion proteins... Asclepiumm是專注於未被滿足醫療需求的市場首見藥物新藥開發公司，研究開發創新ASC融合蛋白平台與獨創胜肽藥物開發市場首見 (first in class) 新藥.

Also known as: Asclepiumm Taiwan, Asclepiumm Taiwan Co., Ltd.

Primary location: Hsinchu